Stock Analysis

While private companies own 26% of Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003), individual investors are its largest shareholders with 46% ownership

SZSE:300003
Source: Shutterstock

Key Insights

  • Lepu Medical Technology (Beijing)'s significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • A total of 17 investors have a majority stake in the company with 50% ownership
  • Insiders own 13% of Lepu Medical Technology (Beijing)

Every investor in Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) should be aware of the most powerful shareholder groups. With 46% stake, individual investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Meanwhile, private companies make up 26% of the company’s shareholders.

Let's take a closer look to see what the different types of shareholders can tell us about Lepu Medical Technology (Beijing).

View our latest analysis for Lepu Medical Technology (Beijing)

ownership-breakdown
SZSE:300003 Ownership Breakdown January 30th 2025

What Does The Institutional Ownership Tell Us About Lepu Medical Technology (Beijing)?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

As you can see, institutional investors have a fair amount of stake in Lepu Medical Technology (Beijing). This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Lepu Medical Technology (Beijing)'s earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
SZSE:300003 Earnings and Revenue Growth January 30th 2025

Hedge funds don't have many shares in Lepu Medical Technology (Beijing). Our data shows that China State Shipbuilding Corporation Limited is the largest shareholder with 13% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 12% and 6.7%, of the shares outstanding, respectively. Zhongjie Pu, who is the second-largest shareholder, also happens to hold the title of Chief Technology Officer.

Looking at the shareholder registry, we can see that 50% of the ownership is controlled by the top 17 shareholders, meaning that no single shareholder has a majority interest in the ownership.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Lepu Medical Technology (Beijing)

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our information suggests that insiders maintain a significant holding in Lepu Medical Technology (Beijing) Co., Ltd.. Insiders own CN¥2.5b worth of shares in the CN¥19b company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 46% stake in Lepu Medical Technology (Beijing). This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Company Ownership

We can see that Private Companies own 26%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 2 warning signs we've spotted with Lepu Medical Technology (Beijing) (including 1 which is a bit unpleasant) .

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SZSE:300003

Lepu Medical Technology (Beijing)

Lepu Medical Technology (Beijing) Co., Ltd.

Excellent balance sheet and fair value.

Community Narratives

Leading the Game with Growth, Innovation, and Exceptional Returns
Fair Value SEK 300.00|50.46000000000001% undervalued
Investingwilly
Investingwilly
Community Contributor
Why ASML Dominates the Chip Market
Fair Value €864.91|18.292% undervalued
yiannisz
yiannisz
Community Contributor
Global Payments will reach new heights with a 34% upside potential
Fair Value US$142.00|20.485999999999997% undervalued
Maxell
Maxell
Community Contributor